Publication | Closed Access

High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era

Hematological MalignancyLymphoid NeoplasiaMedicineBone Marrow InvolvementHematologyPathologyRituximab EraOncologyRadiologyHealth Sciences